Effects of Extracorporeal Shock Wave Therapy Added To Complex DecongestiveTherapy In Patıent With Lymphedeme
Lymphedema, Breast Cancer
About this trial
This is an interventional treatment trial for Lymphedema, Breast Cancer focused on measuring Lymphedema, Complex DecongestiveTherapy, Extracorporeal Shock Wave Therapy
Eligibility Criteria
Inclusion Criteria:
- Be over 18 years old
- History of lymphedema for at least 6 months after breast cancer treatment
- Ending radiotherapy treatment at least 2 months ago
- Not being included in the Complex DecongestiveTherapy program within 3 months
- Having unilateral lymphedema
- Having stage 2 lymphedema
- Signing of the voluntary consent form
- Patients who have undergone oncological follow-up for breast cancer in the last 6 months and have been shown to be free of recurrence and metastasis
Exclusion Criteria:
- Active cancer
- Skin infection, radiotherapy burn
- Severely affected upper extremity range of motion 4 kidney failure
5. Heart failure 6. History of untreated deep venous thrombosis 7. Body mass index I≥35 kg/m2 8. Using a pacemaker/internal defibrillator 9. Patients continuing radiotherapy and/or chemotherapy treatment 10. Having bilateral lymphedema 11. Pregnancy
Sites / Locations
- Kırşehir Ahi Evran University Faculty of MedicineRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Other
Experimental Group
control group
A Complex decongestive treatment program consisting of manual lymphatic drainage, compression therapy, skin care and remedal exercise will be applied to the patients in this group. Exercise progame includes breathing exercises, joint range of motion exercise, pumping, stretching exercises and aerobic exercises( same with control grup). In addition, ESWT will be applied as 2 sessions in the first two weeks and 1 session in the 3rd week. In ESWT, 2500 shocks will be applied per session with a frequency of 4 Hz at 2 bar pressure while the patient is in the supine position. The distribution of this treatment is planned to be 750 shocks to the axillary lymph nodes and 250 shocks to the cubital lymph nodes. The remaining 1500 shocks will be applied to the arm, forearm, and hand. While determining the dose and duration of ESWT to be applied in the study, it was arranged to be similar to the studies and reviews in the literature.
A Complex decongestive treatment program consisting of manual lymphatic drainage, compression therapy, skin care and remedal exercise will be applied to the patients in this group. Exercise progame includes breathing exercises, joint range of motion exercise, pumping, stretching exercises and aerobic exercises